The week in health tech, explained in plain English.Get the free newsletter →
November 12, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Moderna Co-Founder Bets mRNA Cancer Vaccine Will Reshape Biotech

By Healthcare Technology News ·

Kenneth Chien, a co-founder of Moderna who is no longer with the company, says its mRNA cancer vaccine could be transformative for biotechnology, according to a Q&A with STAT News. His comments place the spotlight on the question now driving the mRNA field: whether the platform that delivered Covid-19 vaccines can succeed against cancer.

Moderna's lead oncology candidate, developed with Merck, is a personalized therapeutic vaccine designed to train a patient's immune system to recognize tumor-specific mutations. It pairs with checkpoint inhibitors like Keytruda and has shown early promise in melanoma. Unlike a preventive shot, it is tailored to each patient's tumor, a manufacturing and logistics challenge as much as a scientific one.

Chien's optimism matters because Moderna faces falling Covid revenue and pressure to prove its pipeline can stand on its own. Success in oncology would validate mRNA as a durable therapeutic platform, not a pandemic-era one-off, and would shape investor expectations for the broader sector.

Sources

More in Health IT

Health IT

iRhythm Uses Patient Data to Flag Arrhythmia Risk Earlier

iRhythm's Predictive Arrhythmia Solutions mines EHR and claims data to identify patients for earlier cardiac monitoring instead of waiting for symptoms.

Why it matters: Silent arrhythmias like atrial fibrillation often go undetected until they cause strokes, so using existing data to find at-risk patients earlier could prevent costly and dangerous events.

Health IT

AI Governance in Healthcare Doesn't Stop at Launch

Healthcare Dive argues that AI governance in healthcare is a continuous process of monitoring and accountability, not a one-time approval at launch.

Why it matters: AI models can degrade after deployment, so health systems need ongoing oversight to prevent patient harm and keep clinical tools trustworthy.

Health IT

Healthcare's Revenue Cycle Needs Orchestration, Not More AI

Providers have deployed AI across the revenue cycle, but only 4% have connected the tools, and orchestration is emerging as the fix.

Why it matters: Disconnected AI tools waste investment; orchestrating them is what actually reduces denials and speeds provider payments.